All Posts  |  2022  |  2021

2021

  • “We had collected cord blood units for private banks but never on a large scale prior to our relationship with the Cleveland Cord Blood Center. What a great partnership,” said Michelle Gebhardt, M.D., OBGYN Practitioner at the Kaiser Permanente San [...]

    31 Views
  • The Cleveland Cord Blood Center (CCBC) is in the midst of one of the most exciting times in our history! We can truly say that we’re pursuing new opportunities reflective of our mission at a pace that we could never [...]

    26 Views
  • Glycostem Therapeutics B.V., a leading clinical-stage company focused on the development of therapeutic allogeneic off-the-shelf Natural Killer (NK) cells, has entered into an agreement with Cleveland Cord Blood Center’s state-of-the-art Cleveland Cell Therapy Incubator (CCTI). CCTI is a wholly owned [...]

    41 Views
  • This October, Satyabrata Sinha, Ph.D., joined Cleveland Cord Blood Center’s research staff to lead CCBC’s continued exploration of cord-blood derived stem cell therapy for the treatment of Parkinson’s disease. Sinha has a strong research background with a Ph.D. focused on [...]

    34 Views
  • Cleveland Cord Blood Center’s newest collection site at the Kaiser Permanente San Leandro Medical Center was selected to enhance the diversity of the CCBC cord blood inventory. From its launch in June 2021 through the end of September 2021, 68 [...]

    38 Views

Sign up for our newsletter